<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Alitretinoin; Retinoids: eczema; Toctino; Alitretinoin" /><meta name="IX" content="Toctino; Alitretinoin" /><meta name="IXM" content="Alitretinoin; Retinoids: eczema" /><title>ALITRETINOIN: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP7695-alitretinoin.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP7695-alitretinoin.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP7695-alitretinoin.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP7449-skin.htm">13 Skin</a> &gt; <a href="PHP7686-preparations-for-eczema-and-psoriasis.htm">13.5 Preparations for eczema and psoriasis</a> &gt; <a href="PHP7687-preparations-for-eczema.htm">13.5.1 Preparations for eczema</a> &gt; <a href="PHP7694-oral-retinoid-for-eczema.htm">Oral retinoid for eczema</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP7694-oral-retinoid-for-eczema.htm" title="Previous: Oral retinoid for eczema">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP7697-toctino.htm#PHP7697-toctino" title="Next: Toctino®">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a301047.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alitretinoin (Topical)</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Skin and Mucous Membrane Agents 84:00 &gt; Skin and Mucous Membrane Agents, Miscellaneous 84:92</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/15789-p.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Alitretinoin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: A &gt; Interactions of Alitretinoin</p></div></li></ul><ul><li><h3>British National Formulary (8)</h3></li><li><a href="PHP5583-tretinoin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tretinoin</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs</p></div></li><li><a href="PHP7687-preparations-for-eczema.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">13.5.1 Preparations for eczema</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 13 Skin &gt; 13.5 Preparations for eczema and psoriasis</p></div></li><li><a href="PHP7694-oral-retinoid-for-eczema.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oral retinoid for eczema</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 13 Skin &gt; 13.5 Preparations for eczema and psoriasis &gt; 13.5.1 Preparations for eczema</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22alitretinoin%22%22alitretinoin%22%22retinoids%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (8)</a></li></ul><ul><li><h3>BNF for Children (5)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13817-tretinoin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tretinoin</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP15017-preparations-for-psoriasis.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">13.5.2 Preparations for psoriasis</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 13 Skin &gt; 13.5 Preparations for eczema and psoriasis</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP15063-acitretin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ACITRETIN</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 13 Skin &gt; 13.5 Preparations for eczema and psoriasis &gt; 13.5.2 Preparations for psoriasis &gt; Oral retinoids for psoriasis</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22alitretinoin%22%22alitretinoin%22%22retinoids%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>Dietary Supplements</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c96.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vitamin A</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; V</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/15789-p.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alitretinoin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1590-a2-2-l.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Retinoids</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Dermatological Drugs and Sunscreens &gt; Dermatological Drug Groups</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/00249.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Alitretinoin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; A &gt; AL</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E20E3E0R0D1430.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Alitretinoin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D73.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Retinoids</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; R</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>ALITRETINOIN</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int1124-alitretinoin.htm">Alitretinoin</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">severe chronic hand eczema refractory to potent topical corticosteroids</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">avoid blood donation during treatment and for at least 1 month after stopping treatment; monitor serum lipids (more frequently in those with diabetes, history of hyperlipidaemia, or risk factors for cardiovascular disease)—discontinue if uncontrolled hyperlipidaemia; history of depression; dry eye syndrome; <strong>interactions:</strong> Appendix 1 (retinoids)</p></div> <div id="PHP7696" class="cG"><div class="cE"><h3 class="cT">Pregnancy prevention</h3> <p class="cT">In women of child-bearing potential, exclude pregnancy 1 month before treatment, up to 3 days before treatment, every month during treatment (unless there are compelling reasons to indicate that there is no risk of pregnancy), and 5 weeks after stopping treatment—perform pregnancy test in the first 3 days of the menstrual cycle. Women must practise effective contraception for at least 1 month before starting treatment, during treatment, and for at least 1 month after stopping treatment. Women should be advised to use at least 1 method of contraception but ideally they should use 2 methods of contraception. Oral progestogen-only contraceptives are not considered effective. Barrier methods should not be used alone but can be used in conjunction with other contraceptive methods. Each prescription for alitretinoin should be limited to a supply of up to 30 days' treatment and dispensed within 7 days of the date stated on the prescription. Women should be advised to discontinue treatment and to seek prompt medical attention if they become pregnant during treatment or within 1 month of stopping treatment</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">uncontrolled hyperlipidaemia; uncontrolled hypothyroidism; hypervitaminosis A</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">manufacturer advises avoid—no information available</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">manufacturer advises avoid in severe impairment—no information available</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">avoid—teratogenic; effective contraception must be used—see Pregnancy Prevention <a title="BNF:target-block: Alitretinoin and Pregnancy prevention" href="PHP7695-alitretinoin.htm#PHP7696">above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">manufacturer advises avoid</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">raised serum concentration of triglycerides and of cholesterol (risk of pancreatitis if triglycerides above 9 mmol/litre), flushing; headache; changes in thyroid function tests; anaemia; myalgia, raised creatine kinase, arthralgia; conjunctivitis, dry eyes (may respond to lubricating eye ointment or tear replacement therapy)—sometimes decreased tolerance to contact lenses, eye irritation; dryness of skin and lips, cheilitis, erythema, alopecia; <em>less commonly</em> epistaxis, hyperostosis, ankylosing spondylitis, blurred vision, cataracts, pruritus, and asteototic eczema; <em>rarely</em> benign intracranial hypertension (discontinue if severe headache, nausea, vomiting, papilloedema, or visual disturbances occur) and vasculitis; also reported keratitis and impaired night vision</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p><span class="cP">adult</span> over 18 years, 30 mg once daily, reduced to 10 mg once daily if not tolerated; patients with diabetes, history of hyperlipidaemia, or risk factors for cardiovascular disease, initially 10 mg once daily, increased if necessary up to max. 30 mg daily</p></li>  </ul><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Duration of treatment 12–24 weeks; discontinue if no response after 12 weeks. Course may be repeated in those who relapse. See also Pregnancy Prevention, <a title="BNF:target-block: Alitretinoin and Pregnancy prevention" href="PHP7695-alitretinoin.htm#PHP7696">above</a></p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP7697-toctino.htm#PHP7697-toctino" title="Toctino®">Toctino®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP7694-oral-retinoid-for-eczema.htm">Previous: Oral retinoid for eczema</a> | <a class="top" href="PHP7695-alitretinoin.htm#">Top</a> | <a accesskey="]" href="PHP7697-toctino.htm#PHP7697-toctino" title="Toctino®">Next: Toctino®</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>